CNSOur Range of CNS Techniques

RenaSci provides a wide range of innovative in vitro, ex vivo and in vivo CNS techniques that can be used to determine the mode of action, efficacy and side-effect profile of centrally-acting drugs. These methods can be used to assist the biotech and pharmacological industry to develop better drugs to treat a range of CNS disorders including depression, anxiety, schizophrenia, attention deficit hyperactivity disorder (ADHD), binge-eating disorder, Parkinson’s Disease and Alzheimers Disease.